Delphine Boche

Summary

Affiliation: University of Southampton
Country: UK

Publications

  1. ncbi Atypical inflammation in the central nervous system in prion disease
    V Hugh Perry
    CNS Inflammation Group, School of Biological Sciences, University of Southampton, Southampton SO16 7PX, UK
    Curr Opin Neurol 15:349-54. 2002
  2. ncbi Review: activation patterns of microglia and their identification in the human brain
    D Boche
    Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
    Neuropathol Appl Neurobiol 39:3-18. 2013
  3. ncbi Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis
    Delphine Boche
    Division of Clinical Neurosciences, School of Medicine, Southampton General Hospital, University of Southampton, Southampton SO16 6YD, UK
    Acta Neuropathol 120:369-84. 2010
  4. ncbi Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease
    Delphine Boche
    Southampton General Hospital, University of Southampton, UK
    Acta Neuropathol 120:13-20. 2010
  5. ncbi Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain
    D Boche
    Division of Clinical Neurosciences, University of Southampton, Southampton General Hospital, Southampton, UK
    Brain 131:3299-310. 2008
  6. ncbi The role of the immune system in clearance of Abeta from the brain
    Delphine Boche
    Division of Clinical Neurosciences, University of Southampton, Southampton, UK
    Brain Pathol 18:267-78. 2008
  7. ncbi TGFbeta1 regulates the inflammatory response during chronic neurodegeneration
    Delphine Boche
    CNS Inflammation Group, Southampton Neurosciences Group, School of Biological Sciences, University of Southampton, Southampton, SO16 7PX Hampshire, UK
    Neurobiol Dis 22:638-50. 2006
  8. ncbi Immunotherapy for Alzheimer's disease and other dementias
    Delphine Boche
    Division of Clinical Neurosciences, University of Southampton, School of Medicine, Southampton General Hospital, Southampton, SO16 6YD, UK
    Curr Opin Neurol 18:720-5. 2005
  9. ncbi Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo
    Delphine Boche
    CNS Inflammation Group, Southampton Neuroscience Group, School of Biological Sciences, University of Southampton, Southampton, Hampshire, UK
    J Cereb Blood Flow Metab 23:1174-82. 2003
  10. ncbi Abeta species removal after abeta42 immunization
    James A R Nicoll
    Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, UK
    J Neuropathol Exp Neurol 65:1040-8. 2006

Detail Information

Publications15

  1. ncbi Atypical inflammation in the central nervous system in prion disease
    V Hugh Perry
    CNS Inflammation Group, School of Biological Sciences, University of Southampton, Southampton SO16 7PX, UK
    Curr Opin Neurol 15:349-54. 2002
    ..There is also now evidence to suggest that a peripheral infection, and its consequent systemic cytokine expression, may drive central nervous system cytokine expression and perhaps exacerbate disease...
  2. ncbi Review: activation patterns of microglia and their identification in the human brain
    D Boche
    Clinical Neurosciences, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
    Neuropathol Appl Neurobiol 39:3-18. 2013
    ....
  3. ncbi Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis
    Delphine Boche
    Division of Clinical Neurosciences, School of Medicine, Southampton General Hospital, University of Southampton, Southampton SO16 6YD, UK
    Acta Neuropathol 120:369-84. 2010
    ..The information obtained will be important in helping to understand the pathogenesis not only of AD but also of other neurodegenerative disorders associated with protein aggregation...
  4. ncbi Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease
    Delphine Boche
    Southampton General Hospital, University of Southampton, UK
    Acta Neuropathol 120:13-20. 2010
    ..However, the continuing progression of cognitive decline in AD patients after Abeta immunisation may be explained by its lack of apparent effect on tangles...
  5. ncbi Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain
    D Boche
    Division of Clinical Neurosciences, University of Southampton, Southampton General Hospital, Southampton, UK
    Brain 131:3299-310. 2008
    ..The extent to which these vascular alterations following Abeta immunization in Alzheimer's disease are reflected in changes in cognitive function remains to be determined...
  6. ncbi The role of the immune system in clearance of Abeta from the brain
    Delphine Boche
    Division of Clinical Neurosciences, University of Southampton, Southampton, UK
    Brain Pathol 18:267-78. 2008
    ..In animal models, immunotherapy at an early age can protect against Abeta accumulation and it will be interesting to see if this can usefully be applied to humans to prevent AD...
  7. ncbi TGFbeta1 regulates the inflammatory response during chronic neurodegeneration
    Delphine Boche
    CNS Inflammation Group, Southampton Neurosciences Group, School of Biological Sciences, University of Southampton, Southampton, SO16 7PX Hampshire, UK
    Neurobiol Dis 22:638-50. 2006
    ..These data suggest that TGFbeta1 plays a critical role in the downregulation of microglial responses minimizing brain inflammation and thus avoiding exacerbation of brain damage...
  8. ncbi Immunotherapy for Alzheimer's disease and other dementias
    Delphine Boche
    Division of Clinical Neurosciences, University of Southampton, School of Medicine, Southampton General Hospital, Southampton, SO16 6YD, UK
    Curr Opin Neurol 18:720-5. 2005
    ..The aim of this article is to review the role of immunotherapy in the removal of proteins which accumulate abnormally in neurodegenerative disorders associated with dementia, in particular amyloid-beta accumulation in Alzheimer's disease...
  9. ncbi Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo
    Delphine Boche
    CNS Inflammation Group, Southampton Neuroscience Group, School of Biological Sciences, University of Southampton, Southampton, Hampshire, UK
    J Cereb Blood Flow Metab 23:1174-82. 2003
    ..We have demonstrated in vivo that the cerebral tolerance phenomenon induced by LPS pretreatment is mediated by TGF-beta 1 cytokine...
  10. ncbi Abeta species removal after abeta42 immunization
    James A R Nicoll
    Division of Clinical Neurosciences, School of Medicine, University of Southampton, Southampton, UK
    J Neuropathol Exp Neurol 65:1040-8. 2006
    ..Abeta immunotherapy can clear all Abeta species from the cortex. However, if it is to be used for treatment of established Alzheimer disease, then the residual tau pathology and cerebral amyloid angiopathy require further study...
  11. ncbi Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease
    Colm Cunningham
    CNS Inflammation Group, School of Biological Sciences, Bassett Crescent East, Southampton, Hampshire SO16 7PX, United Kingdom
    J Virol 79:5174-84. 2005
    ..We also propose that serum cytokine and APP measurements are not useful during preclinical disease. Possible consequences of the clear chronic elevation of APPs in the CNS are discussed...
  12. ncbi Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
    Clive Holmes
    Division of Clinical Neurosciences, University of Southampton, Southampton, UK Moorgreen Hospital, Hampshire Partnership Trust, Southampton, UK
    Lancet 372:216-23. 2008
    ..Our aim was to assess the relation between Abeta(42) immune response, degree of plaque removal, and long-term clinical outcomes...
  13. ncbi Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy
    Roy O Weller
    Clinical Neurosciences, University of Southampton School of Medicine, LD74, South Laboratory and Pathology Block, Southampton General Hospital, Southampton SO166YD, UK
    Acta Neuropathol 118:87-102. 2009
    ..Drainage of Abeta along perivascular pathways in ageing artery walls may need to be improved to maximise the potential for improvement of cognitive function with immunotherapy...
  14. ncbi Mannose receptor expression specifically reveals perivascular macrophages in normal, injured, and diseased mouse brain
    Ian Galea
    CNS Inflammation Group, School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton SO16 7PX, UK
    Glia 49:375-84. 2005
    ....
  15. ncbi Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy
    Elina Zotova
    Division of Clinical Neurosciences, School of Medicine, University of Southampton, Mailpoint 806, Level D, South Pathology Block, Southampton General Hospital, Southampton, SO16 6YD, UK
    Alzheimers Res Ther 2:1. 2010
    ....